---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011180"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:30:23.677819+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech lowers warrant exercise price to $0.5424 from $3.20 per Oaktree agreement

## Summary
- Lowered exercise price on 1,749,450 existing warrants from $3.20 to $0.5424 per share.
- Issued amended warrants effective June 13, 2023, expiring August 27, 2030.
- Consideration for Oaktree and lenders allowing company/subsidiaries to take certain actions.
- Warrants originally issued August 2020 under Credit Agreement with Oaktree.

## SEC filing metadata
- accession: 0001558370-23-011180
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000155837023011180/0001558370-23-011180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000155837023011180/fbio-20230613x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011180
- JSON: https://secwatch.observer/filing/0001558370-23-011180.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011180.txt

## Key facts
- Material Agreements
  Fortress Biotech, Inc. amended Letter Agreement regarding Amended and Restated Warrants with Oaktree Fund Administration, LLC and certain affiliates valued at Lowered exercise price of Existing Warrants from $3.20 to $0.5424 per share; issued Amended and Rest (effective 2023-06-13).
  - Action: amendment
  - Counterparty: Oaktree Fund Administration, LLC and certain affiliates
  - Value: Lowered exercise price of Existing Warrants from $3.20 to $0.5424 per share; issued Amended and Rest
  - Effective: 2023-06-13
  source text: On June 13, 2023, the Company entered into a Letter Agreement (the “Letter Agreement”) by and among the Company, the Agent and the Lenders, pursuant to which the Company agreed to lower the exercise price of the Existing Warrants to $0.5424 per share and issue amended and restated warrants reflecting the new exercise price (the “Amended and Restated Warrants”), as consideration for the Agent and Lenders’ agreement to permit the Company and/or certain of its subsidiaries to take certain actions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1429260/000155837023011180/0001558370-23-011180-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.